½ÃÀ庸°í¼­
»óǰÄÚµå
1800788

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå º¸°í¼­ : ½Ã¼ú Á¾·ù, ±â±â À¯Çü, ½Ã¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)

Bariatric Surgery Devices Market Report by Procedure Type, Device Type, Procedure, Application, End-User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 121 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 30¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 46¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025³âºÎÅÍ 2033³â±îÁö 4.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ´ç´¢º´, ºñ¸¸, ½ÉÇ÷°üÁúȯ(CVD) µî ¿©·¯ »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀåÀ» ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù.

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå ºÐ¼®:

  • ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°üÀ¸·Î ÀÎÇÑ Ã¼Áß °ü·Ã ¹®Á¦ÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
  • ÁÖ¿ä ½ÃÀå µ¿Çâ : ÃÖ¼Òħ½À(MI) ºñ¸¸ Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ Å« Àý°³ ¾øÀÌ ¼ö¼ú ÈÄ ½ºÆ®·¹½º¸¦ ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ´Â ±â±â°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
  • °æÀï »óȲ : ½ÃÀå ³» ÁÖ¿ä ±â¾÷À¸·Î´Â Apollo Endosurgery Inc., GI Dynamics, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic Inc., Olympus Corporation, Reach Surgical Inc., Reshape Lifesciences Inc., Spatz Fgia Inc., TransEnterix Inc., USGI Medical Inc. µîÀÌ ÀÖ½À´Ï´Ù.
  • Áö¸®Àû µ¿Çâ : ºÏ¹Ì¿¡¼­´Â ¼ö¼ú¿ë ·Îº¿ÀÇ º¸±ÞÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÅëÁõÀ» ÃÖ¼ÒÈ­ÇÏ°í ¹Ì¿ë È¿°ú¸¦ ³ôÀÎ ±â±â °³¹ßÀÌ ÀÌ Áö¿ª ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
  • µµÀü°ú ±âȸ : ±â±â¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª º¸Çè Àû¿ë È®´ë°¡ ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀåÀ» Ȱ¼ºÈ­½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå µ¿Çâ:

ºñ¸¸ Áõ°¡

¹Ù»Û ÀÏÁ¤°ú ÁÂ½Ä »ýȰ·Î ÀÎÇØ üÁß °ü¸®ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ºñ¸¸ ¼ö¼ú°ú °°Àº ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±ä±ÞÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÓ»ó °á°ú¸¦ °³¼±Çϱâ À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ÅõÀÚ°¡ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù, Phenomix Sciences´Â ÇÑ ¹øÀÇ °Ë»ç·Î ¼¼ °¡Áö ÁÖ¿ä ºñ¸¸ Ç¥ÇöÇüÀ» ¸ðµÎ ½Äº°ÇÏ´Â »õ·Î¿î MyPhenome °Ë»ç¸¦ Ãâ½ÃÇß½À´Ï´Ù.

AI¿ÍÀÇ ÅëÇÕ ¹ßÀü

¸Ó½Å·¯´×°ú AI´Â º¸´Ù ½º¸¶Æ®ÇÏ°í µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ ¼ö¼úÀ» °¡´ÉÇϰÔÇÔÀ¸·Î½á ½ÃÀåÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¼ö¼ú Áß ¾È³», ¼ö¼ú Àü °èȹ, ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µÀ» ´õ¿í Áö¿øÇÏ¿© ¼ö¼ú °á°ú¸¦ °³¼±ÇÕ´Ï´Ù. 2024³â 4¿ù, Allurion Technologies, Inc.´Â ¹Ì±¹¿¡¼­ ÀΰøÁö´É(AI)À» žÀçÇÑ Á¾ÇÕÀûÀÎ VCS(Virtual Care Suite)ÀÇ »ó¿ëÈ­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ´Â ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå Àü¸Á¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

½Ã¼ú °­È­¿¡ ´ëÇÑ °ü½É Áõ°¡

ȯÀÚ¿¡°Ô ´õ ¾ÈÀüÇϰí ȸº¹ ½Ã°£ÀÌ ÂªÀº ¿É¼ÇÀ» Á¦°øÇØ¾ß ÇÒ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀÌ È°¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. À§ ¿ìȸ¼úÀ̳ª º¹°­°æ ½½¸®ºêÇü À§ÀýÁ¦¼ú°ú °°Àº ½Ã¼ú¿¡´Â ÀÛÀº Àý°³¿Í ¿¡Æ¼ÄÜÀÇ Echelon Flex (TM) GST System°ú °°Àº ÷´Ü µµ±¸°¡ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¿Ü°úÀû ¿Ü»ó°ú ¼ö¼ú ÈÄ ÅëÁõÀ» ÃÖ¼ÒÈ­ÇÏ¿© ȯÀÚ¿Í ¿Ü°úÀÇ»ç ¸ðµÎ¿¡°Ô ¸Å·ÂÀûÀÎ ½Ã¼úÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : ½Ã¼ú Á¾·ùº°

  • ÃÖ¼Òħ½À ¼ö¼ú
  • ºñħ½À¼º ¿Ü°ú¼ö¼ú

Á¦7Àå ½ÃÀå ³»¿ª : ±â±â À¯Çüº°

  • º¸Á¶ ±â±â
    • ÁÖ¿ä Á¾·ù
      • ½ºÅ×ÀÌÇà ±â±â
      • ¿¡³ÊÁö ±â¹Ý ¿ë±â ¾Á ±â±â
      • ºÀÇÕ ±â±¸
      • Åõ°üħ
      • Ŭ¸³ ¾îÇöóÀ̾î
      • ±âŸ
  • À̽ÄÇü ±â±â
    • ÁÖ¿ä Á¾·ù
      • À§ ¹êµå
      • Àü±â Àڱرâ
      • À§³» dz¼±
      • °æÀ¯¹® ¼ÅƲ
      • ±âŸ

Á¦8Àå ½ÃÀå ³»¿ª : ½Ã¼úº°

  • À§¼Ò¸ÅÀýÁ¦¼ú
  • Á¶Àý¼ºÀ§¹êµù
  • ·ç¿ÍÀÌ À§¿ìȸ¼ú
  • ½ÊÀÌÁöÀå ½ºÀ§Ä¡¸¦ ¼ö¹ÝÇÏ´Â ´ãÃé ¿ìȸ¼ú
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • °¨·®
  • À¯Àü¼º Áúȯ
  • ±âŸ Àå¾Ö

Á¦10Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • ºñ¸¸¿Ü°ú Ŭ¸®´Ð
  • º´¿ø
  • ±âŸ

Á¦11Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå SWOT ºÐ¼®

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °¡°Ý ÁöÇ¥

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Apollo Endosurgery Inc.
    • GI Dynamics
    • Intuitive Surgical Inc.
    • Johnson & Johnson Services Inc.
    • Medtronic Inc.
    • Olympus Corporation
    • Reach Surgical Inc.
    • Reshape Lifesciences Inc.
    • Spatz Fgia Inc.
    • TransEnterix Inc.
    • USGI Medical Inc.
KSM 25.09.04

The global bariatric surgery devices market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033. The growing prevalence of several lifestyle disorders, such as diabetes, obesity, and cardiovascular diseases (CVDs), is stimulating the market.

Bariatric Surgery Devices Market Analysis:

  • Major Market Drivers: The increasing prevalence of weight-related problems, owing to unhealthy dietary patterns, is propelling the market.
  • Key Market Trends: The rising preferences for minimally invasive (MI) bariatric procedures and devices that eliminate the requirement for large incisions and cause minimal postoperative stress are bolstering the market.
  • Competitive Landscape: Some of the prominent companies in the market include Apollo Endosurgery Inc., GI Dynamics, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic Inc., Olympus Corporation, Reach Surgical Inc., Reshape Lifesciences Inc., Spatz Fgia Inc., TransEnterix Inc., and USGI Medical Inc., among many others.
  • Geographical Trends: The growing adoption of surgical robots is fueling the market in North America. Besides this, the development of devices with minimal pain and enhanced cosmetic results is contributing to the regional market.
  • Challenges and Opportunities: The high costs related to devices are hindering the market. However, the growing insurance coverage will continue to fuel the market in the coming years.

Bariatric Surgery Devices Market Trends:

Rising Incidences of Obesity

Due to hectic schedules and sedentary lifestyles, there is an escalating requirement for weight management practices, thereby highlighting the urgent need for medical solutions like bariatric surgery. Moreover, extensive investments in R&D activities to improve clinical outcomes are propelling the market. For instance, in April 2024, Phenomix Sciences launched a new MyPhenome test that identifies all three key obesity phenotypes in a single test.

Growing Integration of AI

Machine learning and AI are transforming the market by enabling smarter, data-driven surgical procedures. These technologies further aid in intraoperative guidance, preoperative planning, and postoperative monitoring, thereby enhancing the outcomes. In April 2024, Allurion Technologies, Inc. announced the commercial availability of its comprehensive Virtual Care Suite (VCS) powered by artificial intelligence (AI) in the United States. This is positively influencing the bariatric surgery devices market outlook.

Increasing Focus on Enhanced Procedures

The growing need to provide patients with safer options with faster recovery times is catalyzing the market. These techniques, such as gastric bypass and laparoscopic sleeve gastrectomy, involve small incisions and advanced tools like the Echelon Flex(TM) GST System from Ethicon. These innovations minimize surgical trauma and postoperative pain, thereby making the procedures more appealing to patients and surgeons alike.

Global Bariatric Surgery Devices Industry Segmentation:

Breakup by Procedure Type:

  • Minimally Invasive Surgical Procedures
  • Non-Invasive Surgical Procedures

Minimally invasive surgical procedures dominate the market

Minimally invasive surgical procedures improve patient outcomes. Medtronic's Hugo robotic-assisted surgery system is designed to accelerate recovery times. This is escalating the bariatric surgery devices market demand.

Breakup by Device Type:

  • Assisting Devices
    • Stapling Devices
    • Energy Based Vessel Sealing Devices
    • Suturing Devices
    • Trocars
    • Clip Appliers
    • Others
  • Implantable Devices
    • Gastric Bands
    • Electrical Stimulators
    • Gastric Balloons
    • Transpyloric Shuttle
    • Others

Assisting devices (suturing devices) currently hold most of the total bariatric surgery devices market share

Assisting devices, particularly suturing devices, aid in improving surgical efficiency. Companies like Ethicon and Medtronic have been at the forefront of these innovations.

Breakup by Procedure:

  • Sleeve Gastrectomy
  • Adjustable Gastric Banding
  • Roux-en-Y Gastric Bypass
  • Biliopancreatic Diversion with Duodenal Switch
  • Others

Roux-en-Y gastric bypass holds the majority of the global bariatric surgery devices market revenue

Roux-en-Y gastric bypass (RYGB) leads to significant weight loss and improved metabolic health. For instance, Ethicon's Echelon Circular Powered Stapler offers surgeons high precision during the anastomosis phase.

Breakup by Application:

  • Weight Loss
  • Hereditary Disease
  • Other Disorders

Weight loss dominates the bariatric surgery devices market statistics

Bariatric surgery devices play a crucial role in facilitating weight loss. They include suturing tools, advanced staplers, and laparoscopic instruments.

Breakup by End-User:

  • Bariatric Surgery Clinics
  • Hospitals
  • Others

Bariatric surgery clinics dominate the market

Bariatric surgery clinics improve patient care and outcomes. For instance, European Weight Loss Clinics integrated ORBERA(R) intragastric balloons, a non-surgical weight loss solution that assists patients in losing weight before or instead of surgery.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the bariatric surgery devices market overview, the widespread adoption of robotic-assisted surgery is acting as a significant growth-inducing factor. Moreover, the rising focus of individuals in weight management is also driving the regional market. As per the IMARC, the United States weight management market size reached US$ 78.5 Billion in 2023. Looking forward, IMARC Group projects the market to reach US$ 127.2 Billion by 2032, thereby exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major bariatric surgery devices market companies have also been provided. Some of the key players in the market include:

  • Apollo Endosurgery Inc.
  • GI Dynamics
  • Intuitive Surgical Inc.
  • Johnson & Johnson Services Inc.
  • Medtronic Inc.
  • Olympus Corporation
  • Reach Surgical Inc.
  • Reshape Lifesciences Inc.
  • Spatz Fgia Inc.
  • TransEnterix Inc.
  • USGI Medical Inc.

Key Questions Answered in This Report

  • 1.How big is the global bariatric surgery devices market?
  • 2.What is the expected growth rate of the global bariatric surgery devices market during 2025-2033?
  • 3.What are the key factors driving the global bariatric surgery devices market?
  • 4.What has been the impact of COVID-19 on the global bariatric surgery devices market?
  • 5.What is the breakup of the global bariatric surgery devices market based on the procedure type?
  • 6.What is the breakup of the global bariatric surgery devices market based on the device type?
  • 7.What is the breakup of the global bariatric surgery devices market based on the procedure?
  • 8.What is the breakup of the global bariatric surgery devices market based on the application?
  • 9.What is the breakup of the global bariatric surgery devices market based on the end user?
  • 10.What are the key regions in the global bariatric surgery devices market?
  • 11.Who are the key players/companies in the global bariatric surgery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bariatric Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure Type

  • 6.1 Minimally Invasive Surgical Procedures
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Invasive Surgical Procedures
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Assisting Devices
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Stapling Devices
      • 7.1.2.2 Energy Based Vessel Sealing Devices
      • 7.1.2.3 Suturing Devices
      • 7.1.2.4 Trocars
      • 7.1.2.5 Clip Appliers
      • 7.1.2.6 Others
    • 7.1.3 Market Forecast
  • 7.2 Implantable Devices
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Gastric Bands
      • 7.2.2.2 Electrical Stimulators
      • 7.2.2.3 Gastric Balloons
      • 7.2.2.4 Transpyloric Shuttle
      • 7.2.2.5 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Procedure

  • 8.1 Sleeve Gastrectomy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adjustable Gastric Banding
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Roux-en-Y Gastric Bypass
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Biliopancreatic Diversion with Duodenal Switch
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Weight Loss
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hereditary Disease
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Other Disorders
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Bariatric Surgery Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Apollo Endosurgery Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 GI Dynamics
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Intuitive Surgical Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Johnson & Johnson Services Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Medtronic Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Olympus Corporation
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Reach Surgical Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Reshape Lifesciences Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
    • 16.3.9 Spatz Fgia Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 TransEnterix Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 USGI Medical Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦